NIGP 46517: Clinical Chemical Analysis Systems, Automatic: Colorimetric, Ion Electrode, Titrating, etc.

NIGP 46517 Clinical Chemical Analysis Systems, Automatic: Colorimetric, Ion Electrode, Titrating, Etc. is an Item code that captures automated laboratory and pharmacy dispensing equipment state and local governments buy to support clinical diagnostics, medication distribution, and supply chain management across healthcare facilities. State and local health systems, public hospital networks, and county health departments solicit under this code for high-volume automated systems that improve accuracy, efficiency, and inventory visibility in centralized or distributed clinical operations. Harris Health System, a public healthcare provider in Harris County, Texas, represents the dominant recent user, soliciting an automated pharmacy dispensing system (RFP #260061, due March 30, 2026) designed for centralized distribution across two inpatient central pharmacies, multiple specialty clinics, an infusion center, and sixteen ambulatory care clinics with HL7-based Epic Willow Inventory integration and deployment at the Holly Hall Central Distribution Center by September 2027.

Geographic activity concentrates in Texas and the Pacific Northwest, with Harris Health's Texas procurement and Sourcewell's cooperative purchasing framework (RFP #061626, due June 16, 2026) serving Washington state counties including Franklin, Grant, Grays Harbor, Chelan, and Yakima as primary recent activity. The Harris Health solicitation weights pricing at 35 percent, solution design at 35 percent, and vendor qualifications at 30 percent, with mandatory M/WBE utilization requirements, HIPAA compliance, comprehensive insurance including $1 million professional liability limits, and seven-year cost-of-ownership pricing; pre-proposal conference is scheduled for March 25, 2026. Sourcewell's law enforcement equipment frame (despite its title scope mismatch) aggregates thousands of governmental agencies, school districts, and public entities across the United States and Canada through its cooperative vehicle, signaling potential demand across multiple jurisdictions if clinical systems are included under participating addenda.